Qiagen N.V.Qiagen N.V.Qiagen N.V.

Qiagen N.V.

No trades
Buy QGEN
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪9.37 B‬USD
‪341.30 M‬USD
‪1.97 B‬USD
‪221.24 M‬
Beta (1Y)
0.72
Employees (FY)
‪5.97 K‬
Change (1Y)
−211 −3.42%
Revenue / Employee (1Y)
‪329.36 K‬USD
Net income / Employee (1Y)
‪57.20 K‬USD

About Qiagen N.V.


CEO
Thierry Bernard
Website
Headquarters
Venlo
Founded
1996
ISIN
NL0015001WM6
FIGI
BBG000GTYWL7
QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. The firm assay technologies make these biomolecules visible and ready for analysis. Its bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996, and is headquartered in Venlo, the Netherlands.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
A3L06J
QIAGEN 24/31 CV
Yield to maturity
2.70%
Maturity date
Sep 10, 2031
QGEN5328376
QIAGEN N.V. 0.0% 17-DEC-2027
Yield to maturity
2.30%
Maturity date
Dec 17, 2027
QGEN5031116
QIAGEN N.V. 1.0% 13-NOV-2024
Yield to maturity
1.23%
Maturity date
Nov 13, 2024

Explore more bonds 

Frequently Asked Questions


The current price of QGEN is 42.10 USD — it has increased by 0.98% in the past 24 hours. Watch Qiagen N.V. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Qiagen N.V. stocks are traded under the ticker QGEN.
QGEN stock has risen by 0.07% compared to the previous week, the month change is a −6.90% fall, over the last year Qiagen N.V. has showed a 9.22% increase.
We've gathered analysts' opinions on Qiagen N.V. future price: according to them, QGEN price has a max estimate of 61.11 USD and a min estimate of 42.50 USD. Watch QGEN chart and read a more detailed Qiagen N.V. stock forecast: see what analysts think of Qiagen N.V. and suggest that you do with its stocks.
QGEN reached its all-time high on Jul 17, 2000 with the price of 62.63 USD, and its all-time low was 1.87 USD and was reached on Jul 16, 1996. View more price dynamics on QGEN chart.
See other stocks reaching their highest and lowest prices.
QGEN stock is 1.19% volatile and has beta coefficient of 0.72. Track Qiagen N.V. stock price on the chart and check out the list of the most volatile stocks — is Qiagen N.V. there?
Today Qiagen N.V. has the market capitalization of ‪9.37 B‬, it has increased by 1.54% over the last week.
Yes, you can track Qiagen N.V. financials in yearly and quarterly reports right on TradingView.
Qiagen N.V. is going to release the next earnings report on Nov 6, 2024. Keep track of upcoming events with our Earnings Calendar.
QGEN earnings for the last quarter are 0.55 USD per share, whereas the estimation was 0.52 USD resulting in a 5.66% surprise. The estimated earnings for the next quarter are 0.54 USD per share. See more details about Qiagen N.V. earnings.
Qiagen N.V. revenue for the last quarter amounts to ‪496.35 M‬ USD, despite the estimated figure of ‪495.45 M‬ USD. In the next quarter, revenue is expected to reach ‪491.20 M‬ USD.
QGEN net income for the last quarter is ‪−183.46 M‬ USD, while the quarter before that showed ‪80.67 M‬ USD of net income which accounts for −327.41% change. Track more Qiagen N.V. financial stats to get the full picture.
Qiagen N.V. dividend yield was 0.00% in 2023, and payout ratio reached 0.00%. The year before the numbers were 0.00% and 0.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Oct 31, 2024, the company has ‪5.97 K‬ employees. See our rating of the largest employees — is Qiagen N.V. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Qiagen N.V. EBITDA is ‪659.61 M‬ USD, and current EBITDA margin is 33.10%. See more stats in Qiagen N.V. financial statements.
Like other stocks, QGEN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Qiagen N.V. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Qiagen N.V. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Qiagen N.V. stock shows the sell signal. See more of Qiagen N.V. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.